Coeptis Therapeutics To Acquire AI-Powered Marketing Platform For Biotech And Pharma Industries

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company advancing cutting-edge cell therapy platforms for cancer, autoimmune, and infectious diseases, has entered into a Binding Letter of Intent to acquire NexGenAI Affiliates Network. Developed by NexGenAI Solutions Group and its affiliates, this platform integrates AI-driven marketing tools and robotic process automation (RPA) capabilities. This strategic move enables Coeptis to incorporate advanced AI and automation technologies, boosting operational efficiency and unlocking new growth avenues, all while staying committed to its core mission of biopharmaceutical innovation.

Dave Mehalick, President and CEO of Coeptis Therapeutics, said in a statement, "We are excited to integrate NexGenAI Affiliates Network and groundbreaking AI and RPA-driven tools into our offerings. In industries like biotech, pharma, and MLM, where competition is so high and regulatory challenges are complex, having advanced tools to optimize marketing, streamline operations, and drive measurable results is critical."

NexGenAI’s advanced suite of marketing tools harnesses the power of AI and RPA to enhance campaign performance, simplify workflows, and deliver valuable insights. Through this acquisition, Coeptis aims to provide these cutting-edge solutions to businesses navigating the challenges of competitive and tightly regulated industries, including biotech, pharmaceuticals, and multi-level marketing (MLM). These tools empower companies to execute more intelligent, efficient marketing strategies, optimizing time and resources while ensuring compliance with stringent regulatory standards.

Anshuman Dash, Lead Advisory behind the development of NexGenAI Affiliates Network, also stated that "The integration of NexGenAI's innovative AI-powered marketing solutions with Coeptis Therapeutics' forward-thinking approach marks a transformative step forward. This acquisition not only validates the cutting-edge technology we've developed but also aligns with Coeptis' mission to drive innovation in highly regulated industries. Together, we aim to revolutionize marketing strategies and operational efficiencies, ultimately delivering greater value to our partners and the industries we serve.”